Key Takeaway: Dr. Kevin D. Fowler has joined Immuneering, bringing significant expertise in biology and computational biology. He earned his Ph.D. in Chemical Engineering from MIT, where his research concentrated on computational immunology and signal integration in immune cell biology. Additionally, he has experience conducting research at Harvard Medical School.
Price reaction · baseline $6.73 (2025-12-26 close) · 33 other IMRX headline(s) in the window, move may be shared
day 0 close · peak
-1%
Market Sentiment Analysis
POSITIVE FACTORS
Dr. Fowler has deep expertise in biology and computational biology.
He completed his Ph.D. at MIT, a prestigious institution.
His research focuses on computational immunology, a critical field.
He has conducted research at Harvard Medical School.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+41%
120-day peak, hindsight
Typical move
11.4%
average across 8 past catalysts
Cash runway
~36 mo
Minimal dilution risk
Lead asset
IMM-1-104 Monotherapy
Phase 1 · Advanced Solid Tumor
Full Press Release Details
Dr. Fowler brings deep expertise in biology and computational biology to our team. He joined Immuneering after completing his Ph.D. in Chemical Engineering at the Massachusetts Institute of Technology. His doctoral research was focused on computational immunology and signal integration in immune cell biology, and he conducted research at Harvard Medical School.
Frequently Asked Questions
What is Dr. Fowler's area of expertise?
Dr. Fowler specializes in biology and computational biology.
Where did Dr. Fowler complete his Ph.D.?
He completed his Ph.D. at the Massachusetts Institute of Technology.
What was the focus of Dr. Fowler's doctoral research?
His research focused on computational immunology and signal integration.
Which institution did Dr. Fowler conduct research at?